NEW YORK –A public-private consortium in Israel will collect samples and sequence genomes from thousands of COVID-19 patients in an effort to identify protective and risk-bearing genetic factors with the hopes of discovering new diagnostic and treatment methods.
Consortium partners include the Israel Ministry of Health, the Israel Innovation Authority, Sourasky (Ichilov) Medical Center, Rambam Health Care Campus, and startup company Geneyx, which offers next-generation sequencing data analysis, interpretation, reporting, and storage products and services.